Senate Files

Bills

H.R. 3433 118th Congress

Give Kids a Chance Act of 2024

Latest action, Sep 24, 2024: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

How the Senate voted

The Senate hasn't taken a roll call on this bill in the Congresses covered.

235 cosponsors

Sponsored by Rep. McCaul, Michael T. [R-TX-10] (Republican). Cosponsors by party, House members included:

  • Democrats
  • Republicans
  • Independents
Cosponsors
137 D · 98 R
  • Democrat
  • Republican
  • Independent
3 senators cosponsoring

Referred to: Senate: Health, Education, Labor, and Pensions Committee; House: Energy and Commerce Committee

Who lobbied on it

Clients whose quarterly lobbying reports named it, each quarter.

28 clientsQ2 2023Q4 2024

The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
7 reports
GSK (FKA GLAXOSMITHKLINE INC.)
6 reports
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
COVINGTON & BURLING LLP
6 reports
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
4 reports
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)
NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES
4 reports
NOVARTIS
4 reports
RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES)
3 reports
ACADIA PHARMACEUTICALS
2 reports
ACADIA PHARMACEUTICALS, INC.
TIBER CREEK GROUP
2 reports
BAYER CORPORATION (CONSOLIDATED REPORT)
2 reports
BIOTECHNOLOGY INNOVATION ORGANIZATION
2 reports
BRIDGEBIO PHARMA, INC.
2 reports
MIGHTY THERAPEUTICS (FMRLY STEALTH BIOTHERAPEUTICS INC.)
2 reports
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS
MASON CONSULTING, LLC
2 reports
NATIONAL BRAIN TUMOR SOCIETY
PORTERFIELD, FETTIG & SEARS, LLC
2 reports
All 25 of 29 clients
ClientLobbying firmReportsReports totalingFromToSenate
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA7$50.1MQ4 2023Q3 2024yes
GSK (FKA GLAXOSMITHKLINE INC.)6$6.7MQ2 2023Q3 2024yes
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INCCOVINGTON & BURLING LLP6$0Q4 2023Q3 2024yes
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)4$1.0MQ1 2024Q3 2024yes
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES4$5.7MQ1 2024Q3 2024yes
NOVARTIS4$6.0MQ1 2024Q3 2024yes
RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES)3$100KQ4 2024Q3 2024yes
ACADIA PHARMACEUTICALS2$730KQ4 2024Q3 2024yes
ACADIA PHARMACEUTICALS, INC.TIBER CREEK GROUP2$0Q4 2024Q3 2024yes
BAYER CORPORATION (CONSOLIDATED REPORT)2$4.1MQ4 2024Q3 2024yes
BIOTECHNOLOGY INNOVATION ORGANIZATION2$3.1MQ4 2024Q3 2024yes
BRIDGEBIO PHARMA, INC.2$500KQ4 2024Q3 2024yes
MIGHTY THERAPEUTICS (FMRLY STEALTH BIOTHERAPEUTICS INC.)2$80KQ4 2024Q3 2024yes
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERSMASON CONSULTING, LLC2$48KQ4 2024Q3 2024yes
NATIONAL BRAIN TUMOR SOCIETYPORTERFIELD, FETTIG & SEARS, LLC2$40KQ4 2024Q3 2024yes
NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION2$389KQ1 2024Q4 2024yes
PATIENTS RISING NOWYC CONSULTING, LLC2$160KQ4 2024Q3 2024yes
PRAXIS PRECISION MEDICINESTHE KPM GROUP DC LLC2$60KQ4 2024Q3 2024yes
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2$300KQ4 2024Q3 2024yes
RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES)FAEGRE DRINKER BIDDLE & REATH LLP2$0Q4 2024Q3 2024yes
SHIONOGI INC.2$170KQ4 2024Q3 2024yes
SPARK THERAPEUTICS, INC.2$430KQ4 2024Q3 2024yes
ST. JUDE CHILDREN'S RESEARCH HOSPITALALSTON & BIRD LLP2$40KQ4 2024Q3 2024yes
YC CONSULTING, LLC ON BEHALF OF PATIENTS RISING NOWLONG STRATEGIES, INC.2$20KQ4 2024Q3 2024yes
AMERICAN SOCIETY OF NEPHROLOGY1$80KQ4 2024Q4 2024yes